| Trial ID: | L7254 |
| Source ID: | NCT06057077
|
| Associated Drug: |
Semaglutide Weekly Injection
|
| Title: |
Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
|
| Acronym: |
|
| Status: |
NOT_YET_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Semaglutide weekly injection
|
| Outcome Measures: |
Primary: change in HA1c and mounts of insulin of basal and bolus which will be taken daily is the same or decreased after one year of follow up, change in A1C and daily insulin requirements will be reduced at the end of one year from study was started, Time Frame: one year | Secondary: the change in weight after follow up of one year, one year
|
| Sponsor/Collaborators: |
Sponsor: Ministry of Health, Saudi Arabia
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2024-01-01
|
| Completion Date: |
2024-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2023-09-28
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT06057077
|
